Company Overview

VIC Technology Venture Development sources top medtech and biotech innovation from research institutions around the world

We select technologies that provide the most significant commercial opportunities and highest societal impacts. VIC forms new companies to commercialize the chosen technologies.

Our growing portfolio of companies is managed by successful business executives and funded through the VIC Investor Network (VIN) and a network of other co-investors.

While VIC’s primary focus is on forming life science companies, we also have founded companies in high-impact areas such as clean water, animal health, food safety, and automotive crash safety.


VIC Ecosystem

VIC built a complete venture development ecosystem
to navigate the challenges and realize the enormous commercial potential of technologies derived from the over $120 billion R&D investment made each year into universities and federal research facilities in the United States.

VIC is headquartered in Fayetteville, Arkansas, and has branch offices across the US. The Arkansas headquarters provides turn-key support at low cost to the portfolio companies, including accounting, human resources, marketing and communications, scientific and engineering expertise, and technical writing.

The branch offices house experienced executive-level team members that serve as the interim CEOs for new portfolio companies in their region. 


Portfolio Company Development

Typically, technologies from universities and federal research labs fail to be developed sufficiently to attract large company or investment interest. Market barriers are significant. Deep technical expertise and specialized business expertise are required.

Current commercialization approaches tend to be fragmented (for example, professors try to lead spin-outs on a part-time basis). All the elements needed for success rarely are pulled together from the beginning.

Technical, competitive, and financial risk may be substantial without the proper expertise to skillfully manage technologies through the commercialization process.

VIC has built an efficient business model and ecosystem for life science technology commercialization. All VIC portfolio companies begin with strong intellectual property (IP) foundations.

VIC’s internal opportunity assessment team screens about 1,500 technologies per year. Only those that pass through VIC’s rigorous Opportunity Assessment process – which includes market research, patent analysis, competitive intelligence, and much more – are selected to be the foundation for a new VIC portfolio company.

VIC’s branch offices build relationships with key IP centers and lead new companies through their early development phases.



Each new VIC portfolio company receives between $250,000 and $500,000 seed investment from the VIC Investor Network (VIN). This investment allows the new company to establish proof-of-concept and position itself for follow-on investment. 

The next investment round is raised from a combination of VIN and outside sources, such as large company partners, who may be future acquirers of the given company.

Are you interested in becoming an investor?
Please visit us at to learn more.